Incyte replaces CEO Hoppenot with dealmaker Meury
BioPharma Drive: Drug Pricing
JUNE 26, 2025
Permission granted by Incyte Dive Brief: Incyte has named veteran pharmaceutical executive Bill Meury as its new CEO, replacing longtime head Hervé Hoppenot, who led the cancer and blood disease drugmaker for the past 11 years. You can unsubscribe at anytime. Last year, Jakafi brought in nearly $2.8 billion in sales.
Let's personalize your content